LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
96901-4 | MDS v3.0 - RAI v1.17.2 - Delirium | - | RptPeriod | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | MDS v3.0 - RAI v1.17.2 - Delirium during assessment period [CMS Assessment] | null | null | ACTIVE | 2.70 | 2.7 |
96902-2 | MDS v3.0 - RAI v1.17.2 - Hearing, speech, and vision - NC, NP, NQ, SP | - | RptPeriod | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | MDS v3.0 - RAI v1.17.2 - Hearing, speech, and vision - NC, NP, NQ, SP during assessment period [CMS Assessment] | null | null | ACTIVE | 2.70 | 2.7 |
96903-0 | MDS v3.0 - RAI v1.17.2 - Cognitive patterns - NC, NP, NQ, SP | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | MDS v3.0 - RAI v1.17.2 - Cognitive patterns - NC, NP, NQ, SP [CMS Assessment] | null | null | ACTIVE | 2.70 | 2.7 |
96904-8 | MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NC | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NC [CMS Assessment] | null | null | ACTIVE | 2.70 | 2.7 |
96905-5 | MDS v3.0 - RAI v1.17.2 - Bladder and bowel - ND, SD | - | RptPeriod | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | MDS v3.0 - RAI v1.17.2 - Bladder and bowel - ND, SD during assessment period [CMS Assessment] | null | null | ACTIVE | 2.70 | 2.7 |
96906-3 | MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NP, NQ, SP | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NP, NQ, SP [CMS Assessment] | null | null | ACTIVE | 2.70 | 2.7 |
96907-1 | MDS v3.0 - RAI v1.17.2 - Cognitive patterns - ND, SD | - | Pt | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | MDS v3.0 - RAI v1.17.2 - Cognitive patterns - ND, SD [CMS Assessment] | null | null | ACTIVE | 2.70 | 2.7 |
96908-9 | MDS v3.0 - RAI v1.17.2 - Staff assessment for mental status | - | RptPeriod | ^Patient | - | CMS Assessment | PANEL.SURVEY.CMS | 4 | MDS v3.0 - RAI v1.17.2 - Staff assessment for mental status during assessment period [CMS Assessment] | null | null | ACTIVE | 2.70 | 2.7 |
9690-9 | Chromium | MCnc | Pt | XXX | Qn | null | DRUG/TOX | 1 | Chromium [Mass/volume] in Specimen | Chromium Spec-mCnc | null | ACTIVE | 1.0i | 2.73 |
96909-7 | Cenobamate | MCnc | Pt | Ser/Plas | Qn | Confirm | DRUG/TOX | 1 | Cenobamate [Mass/volume] in Serum or Plasma by Confirmatory method | Cenobamate SerPl Cfm-mCnc | null | ACTIVE | 2.70 | 2.7 |
96910-5 | Acanthamoeba sp & Naegleria fowleri & Balamuthia mandrillaris DNA panel | - | Pt | XXX | - | null | PANEL.MICRO | 1 | Acanthamoeba sp and Naegleria fowleri and Balamuthia mandrillaris DNA panel - Specimen | Free-living amoeba Pnl Spec | null | ACTIVE | 2.70 | 2.7 |
96911-3 | Delta aminolevulinate & porphobilinogen panel | - | Pt | Ser/Plas | - | null | PANEL.CHEM | 1 | Delta aminolevulinate and porphobilinogen panel - Serum or Plasma | D-ALA + PBG Pnl SerPl | null | ACTIVE | 2.70 | 2.7 |
96912-1 | CT global noise | Rden | Pt | Study | Qn | Calculated | RAD | 2 | Calculated CT global noise | Calc CT global noise | null | ACTIVE | 2.70 | 2.7 |
96913-9 | CT size-adjusted dose | EngCnt | Pt | Study | Qn | Calculated | RAD | 2 | Calculated CT size-adjusted dose | Calc CT size-adj dose | null | ACTIVE | 2.70 | 2.7 |
96914-7 | CT dose & image quality category | Type | Pt | Study | Nom | null | RAD | 2 | CT dose and image quality category | CT dose + image qual | null | ACTIVE | 2.70 | 2.7 |
96915-4 | CT quality measure out of range | Find | Pt | Study | Ord | null | RAD | 2 | CT quality measure out of range | CT qual meas out of range | null | ACTIVE | 2.70 | 2.7 |
96916-2 | Average diameter on axial mid-scan image | Len | Pt | ^Patient | Qn | CT | RAD | 2 | CT Average diameter on axial mid-scan image | CT Avg diam axial mid-scan | null | ACTIVE | 2.70 | 2.7 |
9691-7 | Cobalt | MCnc | Pt | XXX | Qn | null | DRUG/TOX | 1 | Cobalt [Mass/volume] in Specimen | Cobalt Spec-mCnc | null | ACTIVE | 1.0i | 2.7 |
96917-0 | Average diameter on frontal scout image | Len | Pt | ^Patient | Qn | CT | RAD | 2 | CT Average diameter on frontal scout image | CT Avg diam frontal scout | null | ACTIVE | 2.70 | 2.7 |
96918-8 | Fodrin.alpha subunit Ab.IgA | ACnc | Pt | Ser/Plas | Qn | IA | SERO | 1 | Fodrin alpha subunit IgA Ab [Units/volume] in Serum or Plasma by Immunoassay | Fodrin alpha IgA SerPl IA-aCnc | null | ACTIVE | 2.70 | 2.7 |
96919-6 | Nuclear Ab pattern.homogeneous | Titr | Pt | CSF | Qn | IF | SERO | 1 | Homogenous nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence | ANA Homogen Titr CSF IF | null | ACTIVE | 2.70 | 2.7 |
96920-4 | Nuclear Ab pattern.nucleolar | Titr | Pt | CSF | Qn | IF | SERO | 1 | Nucleolar nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence | ANA nucleolar Titr CSF IF | null | ACTIVE | 2.70 | 2.7 |
96921-2 | Nuclear Ab pattern.speckled | Titr | Pt | CSF | Qn | IF | SERO | 1 | Speckled nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence | ANA Speckled Titr CSF IF | null | ACTIVE | 2.70 | 2.7 |
96922-0 | Nuclear Ab pattern.spindle fibers | Titr | Pt | CSF | Qn | IF | SERO | 1 | Spindle fibers nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence | ANA spindle fibers Titr CSF IF | null | ACTIVE | 2.70 | 2.7 |
96923-8 | Nuclear Ab pattern.smooth nuclear envelope | Titr | Pt | CSF | Qn | IF | SERO | 1 | Smooth nuclear envelope nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence | ANA smooth nucl env Titr CSF IF | null | ACTIVE | 2.70 | 2.7 |
96924-6 | Nuclear Ab pattern.intercellular bridge | Titr | Pt | CSF | Qn | IF | SERO | 1 | Intercellular bridge nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence | ANA intercell bridge Titr CSF IF | null | ACTIVE | 2.70 | 2.7 |
9692-5 | Isobutanol | MCnc | Pt | XXX | Qn | null | DRUG/TOX | 1 | Isobutanol [Mass/volume] in Specimen | Isobutanol Spec-mCnc | null | ACTIVE | 1.0i | 2.7 |
96925-3 | Nuclear Ab pattern.nuclear dots | Titr | Pt | CSF | Qn | IF | SERO | 1 | Nuclear dots nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence | ANA nuclear dots Titr CSF IF | null | ACTIVE | 2.70 | 2.7 |
96926-1 | PCNA extractable nuclear Ab | Titr | Pt | CSF | Qn | IF | SERO | 1 | PCNA extractable nuclear Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | ENA PCNA Ab Titr CSF IF | null | ACTIVE | 2.70 | 2.7 |
96927-9 | Nuclear Ab pattern.centrosomal | Titr | Pt | CSF | Qn | IF | SERO | 1 | Centrosomal nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence | ANA centrosomal Titr CSF IF | null | ACTIVE | 2.70 | 2.7 |
96928-7 | Fodrin.alpha subunit Ab.IgG | ACnc | Pt | Ser/Plas | Qn | IA | SERO | 1 | Fodrin alpha subunit IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | Fodrin alpha IgG SerPl IA-aCnc | null | ACTIVE | 2.70 | 2.7 |
96929-5 | Personal well-being panel | - | Pt | ^Patient | - | R-Outcomes | PANEL.SURVEY.R-OUTCOMES | 4 | Personal well-being panel [R-Outcomes] | null | Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: [email protected] Used with permission | ACTIVE | 2.70 | 2.72 |
96930-3 | Personal well-being score | Score | Pt | ^Patient | Qn | R-Outcomes | SURVEY.R-OUTCOMES | 4 | Personal well-being score [R-Outcomes] | null | Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: [email protected] Used with permission | ACTIVE | 2.70 | 2.7 |
96931-1 | How are you feeling in general: I am satisfied with my life | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | How are you feeling in general: I am satisfied with my life | null | null | ACTIVE | 2.70 | 2.7 |
96932-9 | How are you feeling in general: what I do in my life is worthwhile | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | How are you feeling in general: What I do in my life is worthwhile | null | null | ACTIVE | 2.70 | 2.7 |
9693-3 | Mercury | MCnc | Pt | CSF | Qn | null | DRUG/TOX | 1 | Mercury [Mass/volume] in Cerebral spinal fluid | Mercury CSF-mCnc | null | ACTIVE | 1.0i | 2.7 |
96933-7 | How are you feeling in general: I was happy yesterday | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | How are you feeling in general: I was happy yesterday | null | null | ACTIVE | 2.70 | 2.7 |
96934-5 | How are you feeling in general: I was not anxious yesterday | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | How are you feeling in general: I was not anxious yesterday | null | null | ACTIVE | 2.70 | 2.7 |
96935-2 | Heart rate | NRat | XXX^min | Arterial system | Qn | Pedometer | HRTRATE.MOLEC | 2 | Heart rate unspecified time minimum by Pedometer | Heart rate ?Tm Min Pedometer | null | ACTIVE | 2.70 | 2.7 |
96936-0 | Person-specific outcome panel | - | Pt | ^Patient | - | R-Outcomes | PANEL.SURVEY.R-OUTCOMES | 4 | Person-specific outcome panel [R-Outcomes] | null | Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: [email protected] Used with permission | ACTIVE | 2.70 | 2.7 |
96937-8 | Issue you would like help with | Find | Pt | ^Patient | Nom | null | SURVEY.R-OUTCOMES | 4 | Issue you would like help with | null | null | ACTIVE | 2.70 | 2.7 |
96938-6 | How much concern does the issue you would like help with cause | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | How much concern does the issue you would like help with cause | null | null | ACTIVE | 2.70 | 2.7 |
96939-4 | Social contact panel | - | Pt | ^Patient | - | R-Outcomes | PANEL.SURVEY.R-OUTCOMES | 4 | Social contact panel [R-Outcomes] | null | Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: [email protected] Used with permission | ACTIVE | 2.70 | 2.73 |
96940-2 | Social contact score | Score | Pt | ^Patient | Qn | R-Outcomes | SURVEY.R-OUTCOMES | 4 | Social contact score [R-Outcomes] | null | Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: [email protected] Used with permission | ACTIVE | 2.70 | 2.73 |
9694-1 | Propoxur | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Propoxur [Mass/volume] in Serum or Plasma | Propoxur SerPl-mCnc | null | ACTIVE | 1.0i | 2.73 |
96941-0 | Thinking about your friends and family: I have people to talk to | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | Thinking about your friends and family: I have people to talk to | null | null | ACTIVE | 2.70 | 2.7 |
96942-8 | Thinking about your friends and family: I have someone I can confide in | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | Thinking about your friends and family: I have someone I can confide in | null | null | ACTIVE | 2.70 | 2.7 |
96943-6 | Thinking about your friends and family: I have people who will help me | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | Thinking about your friends and family: I have people who will help me | null | null | ACTIVE | 2.70 | 2.7 |
96944-4 | Thinking about your friends and family: I do things with others | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | Thinking about your friends and family: I do things with others | null | null | ACTIVE | 2.70 | 2.7 |
96945-1 | Health confidence panel | - | Pt | ^Patient | - | R-Outcomes | PANEL.SURVEY.R-OUTCOMES | 4 | Health confidence panel [R-Outcomes] | null | Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: [email protected] Used with permission | ACTIVE | 2.70 | 2.72 |
96946-9 | Health confidence score | Score | Pt | ^Patient | Qn | R-Outcomes | SURVEY.R-OUTCOMES | 4 | Health confidence score [R-Outcomes] | null | Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: [email protected] Used with permission | ACTIVE | 2.70 | 2.7 |
96947-7 | How do you feel about caring for your health: I can look after my health | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | How do you feel about caring for your health: I can look after my health | null | null | ACTIVE | 2.70 | 2.7 |
96948-5 | How do you feel about caring for your health: I can get the right help if I need it | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | How do you feel about caring for your health: I can get the right help if I need it | null | null | ACTIVE | 2.70 | 2.7 |
96949-3 | How do you feel about caring for your health: I am involved in decisions about me | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | How do you feel about caring for your health: I am involved in decisions about me | null | null | ACTIVE | 2.70 | 2.7 |
96950-1 | How do you feel about caring for your health: I know enough about my health | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | How do you feel about caring for your health: I know enough about my health | null | null | ACTIVE | 2.70 | 2.7 |
96951-9 | Social determinants of health panel | - | Pt | ^Patient | - | R-Outcomes | PANEL.SURVEY.R-OUTCOMES | 4 | Social determinants of health panel [R-Outcomes] | null | Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: [email protected] Used with permission | ACTIVE | 2.70 | 2.72 |
96952-7 | Social determinants of health score | Score | Pt | ^Patient | Qn | R-Outcomes | SURVEY.R-OUTCOMES | 4 | Social determinants of health score [R-Outcomes] | null | Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: [email protected] Used with permission | ACTIVE | 2.70 | 2.7 |
96953-5 | Thinking about how you live: I have had a good education | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | Thinking about how you live: I have had a good education | null | null | ACTIVE | 2.70 | 2.7 |
96954-3 | Thinking about how you live: I am valued for what I do | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | Thinking about how you live: I am valued for what I do | null | null | ACTIVE | 2.70 | 2.7 |
96955-0 | Thinking about how you live: I am happy about where I live | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | Thinking about how you live: I am happy about where I live | null | null | ACTIVE | 2.70 | 2.7 |
96956-8 | Thinking about how you live: I have enough money to cope | Find | Pt | ^Patient | Ord | null | SURVEY.R-OUTCOMES | 4 | Thinking about how you live: I have enough money to cope | null | null | ACTIVE | 2.70 | 2.7 |
96957-6 | SARS coronavirus 2 M gene | PrThr | Pt | Respiratory.upper | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection | SARS-CoV-2 M gene Upper resp Ql NAA+prb | null | ACTIVE | 2.70 | 2.7 |
9695-8 | 3-Methoxy-4-Hydroxyphenylglycol | MRat | 24H | Urine | Qn | null | CHEM | 1 | 3-Methoxy-4-Hydroxyphenylglycol [Mass/time] in 24 hour Urine | 3Me4OH-phenylglycol 24h Ur-mRate | null | ACTIVE | 1.0i | 2.73 |
96958-4 | SARS coronavirus 2 N gene | PrThr | Pt | Saliva | Ord | Probe.amp.tar.CDC primer-probe set N2 | MICRO | 1 | SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N2 | SARS-CoV-2 N gene Sal Ql NAA N2 | null | ACTIVE | 2.70 | 2.7 |
96959-2 | Cholesterol.in LDL.small dense | SCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Cholesterol.in LDL.small dense [Moles/volume] in Serum or Plasma | Chol.in LDL.small dense SerPl-sCnc | null | ACTIVE | 2.70 | 2.7 |
969-6 | D little u Ab | ACnc | Pt | Ser | Ord | Aggl RBC | BLDBK | 1 | Deprecated D little u Ab | Deprecated Du Ab Ser Ql | null | DEPRECATED | 1.0 | 2.36 |
96960-0 | Varicella zoster virus Ab.IgM Index | ACnc | Pt | Ser+CSF | Qn | null | MICRO | 1 | Varicella zoster virus IgM Ab index [Units/volume] in Serum and CSF | VZV IgM Index Ser+CSF-aCnc | null | ACTIVE | 2.70 | 2.7 |
96961-8 | Varicella zoster virus Ab.IgG Index | ACnc | Pt | Ser+CSF | Qn | null | MICRO | 1 | Varicella zoster virus IgG Ab index [Units/volume] in Serum and CSF | VZV IgG Index Ser+CSF-aCnc | null | ACTIVE | 2.70 | 2.7 |
96962-6 | Bordetella pertussis.pertussis toxin promoter region | PrThr | Pt | Respiratory.lower | Ord | Probe.amp.tar | MICRO | 1 | Bordetella pertussis.pertussis toxin promoter region [Presence] in Lower respiratory specimen by NAA with probe detection | B pert.PT Prmt Lower resp Ql NAA+probe | null | ACTIVE | 2.70 | 2.7 |
96963-4 | Grimontia holisae & Vibrio fluvialis & Vibrio harveyi DNA | Prid | Pt | XXX | Nom | Probe.amp.tar | MICRO | 1 | Grimontia holisae and Vibrio fluvialis and Vibrio harveyi DNA [Identifier] in Specimen by NAA with probe detection | G. hol + V. fluv + harv DNA Spec NAA+Prb | null | ACTIVE | 2.70 | 2.7 |
96964-2 | EZH2 gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.MUT | 1 | EZH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | EZH2 gene Mut Anl Bld/T | null | ACTIVE | 2.70 | 2.7 |
96965-9 | CARD11 gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.MUT | 1 | CARD11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | CARD11 Mut Anl Bld/T | null | ACTIVE | 2.70 | 2.7 |
9696-6 | 8-Hydroxyloxapine | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | 8-Hydroxyloxapine [Mass/volume] in Serum or Plasma | 8OH-Loxapine SerPl-mCnc | null | ACTIVE | 1.0i | 2.73 |
96966-7 | CD79A gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.MUT | 1 | CD79A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | CD79A Mut Anl Bld/T | null | ACTIVE | 2.70 | 2.7 |
96967-5 | CD79B gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.MUT | 1 | CD79B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | CD79B Mut Anl Bld/T | null | ACTIVE | 2.70 | 2.7 |
96968-3 | TNFAIP3 gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.MUT | 1 | TNFAIP3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | TNFAIP3 Mut Anl Bld/T | null | ACTIVE | 2.70 | 2.7 |
96969-1 | MYD88 gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.MUT | 1 | MYD88 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | MYD88 Mut Anl Bld/T | null | ACTIVE | 2.70 | 2.7 |
96970-9 | TP53 gene deletion+duplication | Prid | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.DELDUP | 1 | TP53 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal | TP53 gene Del+Dup Bld/T | null | ACTIVE | 2.70 | 2.7 |
96971-7 | STK11 gene deletion+duplication | Prid | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.DELDUP | 1 | STK11 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal | STK11 gene Del+Dup Bld/T | null | ACTIVE | 2.70 | 2.7 |
96972-5 | PTEN gene deletion+duplication | Prid | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.DELDUP | 1 | PTEN gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal | PTEN gene Del+Dup Bld/T | null | ACTIVE | 2.70 | 2.7 |
96973-3 | CDH1 gene deletion+duplication | Prid | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.DELDUP | 1 | CDH1 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal | CDH1 gene Del+Dup Bld/T | null | ACTIVE | 2.70 | 2.7 |
9697-4 | carBAMazepine 10,11-Epoxide | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Deprecated carBAMazepine 10,11-Epoxide [Mass/volume] in Serum or Plasma | Deprecated carBAMazepine EP SerPl-mCnc | null | DEPRECATED | 1.0i | 2.7 |
96974-1 | PALB2 gene deletion+duplication | Prid | Pt | Bld/Tiss | Nom | Molgen | MOLPATH.DELDUP | 1 | PALB2 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal | PALB2 Del+Dup Bld/T | null | ACTIVE | 2.70 | 2.7 |
96975-8 | Sub-maximal exercise stress test study | Find | Pt | ^Patient | Doc | {Role} | CARDIO-PULM | 2 | Sub-maximal exercise stress test study | SubMax Ex Stress Test | null | ACTIVE | 2.70 | 2.72 |
96976-6 | Carbon dioxide^at end expiration-Carbon dioxide^at end expiration+W sub-maximal exercise | PPresDiff | Pt | Exhl gas | Qn | null | CARDIO-PULM | 2 | Carbon dioxide end tidal baseline - sub-maximal exercise delta | pCO2 baseline-SubMx Exer delta | null | ACTIVE | 2.70 | 2.7 |
96977-4 | Noninvasive prenatal fetal aneuploidy panel | - | Pt | WBC.DNA+Plas.cfDNA | - | Dosage of chromosome specific cf DNA | PANEL.MOLPATH | 1 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA | NIP fet aneu Pnl WBC.DNA+cfDNA | null | ACTIVE | 2.70 | 2.7 |
96978-2 | Noninvasive prenatal fetal aneuploidy & 22q11.2 deletion panel | - | Pt | WBC.DNA+Plas.cfDNA | - | Dosage of chromosome specific cf DNA | PANEL.MOLPATH | 1 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA | NIP aneu + 22q11.2 Pnl WBC.DNA+cfDNA | null | ACTIVE | 2.70 | 2.7 |
96979-0 | Fetal trisomy 13+trisomy 18+triploidy risk | Imp | Pt | WBC.DNA+Plas.cfDNA | Ord | Calculated | MOLPATH | 1 | Trisomy 13, trisomy 18 or triploidy risk [Interpretation] in Plasma cell-free+WBC DNA Qualitative by calculation | T13+T18+Trip risk WBC.DNA+cfDNA Calc-Imp | null | ACTIVE | 2.70 | 2.7 |
96980-8 | Comment on overall fetal aneuploidy risk | Txt | Pt | WBC.DNA+Plas.cfDNA | Nar | Dosage of chromosome specific cf DNA | MOLPATH | 1 | Comment on overall fetal aneuploidy risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative | Comment aneu risk WBC.DNA+cfDNA | null | ACTIVE | 2.70 | 2.7 |
96981-6 | Fetal trisomy 13+trisomy 18+triploidy risk | Likelihood | Pt | WBC.DNA+Plas.cfDNA | Qn | Calculated | MOLPATH | 1 | Trisomy 13, trisomy 18 or triploidy risk [Likelihood] in Plasma cell-free+WBC DNA by calculation | T13+T18+Trip risk WBC.DNA+cfDNA Calc | null | ACTIVE | 2.70 | 2.7 |
9698-2 | Desmethylclomipramine | MCnc | Pt | Ser | Qn | null | DRUG/TOX | 1 | Deprecated Norclomipramine [Mass/volume] in Serum or Plasma | Deprecated Desmethylclomipramine Ser | null | DEPRECATED | 1.0i | 2.7 |
96982-4 | Test result delivery method | Type | Pt | Referral lab test | Nom | null | ADMIN | 2 | Referral lab test result delivery method | Ref lab result delivery method | null | ACTIVE | 2.70 | 2.7 |
96983-2 | Twin pregnancy | Find | Pt | ^Patient | Ord | null | CLIN | 2 | Twin pregnancy | Twin pregnancy | null | ACTIVE | 2.70 | 2.7 |
96984-0 | Chromosome analysis | Find | Pt | POC | Doc | Microarray | MOLPATH | 1 | Chromosome analysis in Products of Conception by Microarray | Chrom analy POC Microarray | null | ACTIVE | 2.70 | 2.7 |
96985-7 | Fetal sex | Type | Pt | POC | Nom | Molgen | MOLPATH | 1 | Sex [Type] in Products of Conception by Molecular genetics method | Sex POC | null | ACTIVE | 2.70 | 2.7 |
96986-5 | SARS coronavirus 2 N gene | PrThr | Pt | Nose | Ord | Non-probe.amp.tar | MICRO | 1 | SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection | SARS-CoV-2 N gene Nose Ql NAA+non-probe | null | ACTIVE | 2.70 | 2.7 |
96987-3 | Mass vaccination status | - | Pt | ^Event | - | CDC.EOC | PANEL.SURVEY.CDC | 4 | Mass vaccination status [CDC Emergency Operations Centers] | null | null | ACTIVE | 2.70 | 2.7 |
96988-1 | CVX code | ID | Pt | Vaccine | Nom | null | VACCIN | 2 | Vaccine CVX code | Vaccine CVX code | null | ACTIVE | 2.70 | 2.7 |
96989-9 | MVX code | ID | Pt | Vaccine | Nom | null | VACCIN | 2 | Vaccine MVX code | Vaccine MVX code | null | ACTIVE | 2.70 | 2.7 |
9699-0 | PARoxetine | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | PARoxetine [Mass/volume] in Serum or Plasma | PARoxetine SerPl-mCnc | null | ACTIVE | 1.0i | 2.73 |
Subsets and Splits
No saved queries yet
Save your SQL queries to embed, download, and access them later. Queries will appear here once saved.